ICUI ICU Medical
ICU Medical earnings company data as of 11:42 AM ET 11/17
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 2.15 | — | — |
| Rev | $554.0M | $560.4M | Beat +1.2% |
Insider trades
Open-market buys and sales by ICUI's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $4.9M sold by 6 insiders outside a trading plan
- $3.5M sold by 2 insiders under 10b5-1 plans
-
David C. Greenberg DirectorSale$156K 883 shares at $176.12 8.7% of stakeTraded Nov 20 Filed Nov 20
-
Elisha W. Finney DirectorSale$316K 1,765 shares at $179.00 27% of stakeTraded Nov 12–13 Filed Nov 13
-
Virginia Ruth Sanzone VP, General CounselPlanned sale$819K 4,856 shares at $168.69 25% of stakeTraded Sep 3 Filed Sep 3
-
Brian Michael Bonnell CFOPlanned sale$1.1M 6,381 shares at $175.00 10% of stakeTraded Sep 1 Filed Sep 1
-
Brian Michael Bonnell CFOPlanned sale$1.6M 9,307 shares at $172.79 13% of stakeTraded Aug 31 Filed Aug 31
-
Daniel Woolson VP, GM-Infusion CapitalSale$982K 5,417 shares at $181.33 24% of stakeTraded Aug 13 Filed Aug 13
-
Ben Sousa Chief Information OfficerSale$401K 2,250 shares at $178.32 42% of stakeTraded Aug 12 Filed Aug 12
-
Christian B. Voigtlander COOSale$1.6M 8,929 shares at $182.93 19% of stakeTraded Aug 11 Filed Aug 11
-
Elisha W. Finney DirectorSale$69K 378 shares at $182.48 7.2% of stakeTraded Aug 11 Filed Aug 11
-
Daniel Woolson PresidentSale$281K 2,123 shares at $132.21 8.6% of stakeTraded May 22 Filed May 22
-
Virginia Ruth Sanzone VP, General CounselSale$304K 2,447 shares at $124.08 11% of stakeTraded May 14 Filed May 15
-
David C. Greenberg DirectorSale$298K 2,424 shares at $122.91 23% of stakeTraded May 12 Filed May 13
-
Daniel Woolson VP, GM-Infusion CapitalSale$441K 2,897 shares at $152.35 20% of stakeTraded Nov 25, 2025 Filed Nov 25, 2025
-
Virginia Ruth Sanzone VP, General CounselSale$132K 930 shares at $142.35 15% of stakeTraded Nov 11, 2025 Filed Nov 12, 2025
-
Elisha W. Finney DirectorSale$180K 1,285 shares at $140.42 24% of stakeTraded Nov 11, 2025 Filed Nov 12, 2025
Also filed in the last 12 months, not counted as buying or selling: 35 option exercises, 25 share withholdings for taxes, and 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.03,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon